Item 16. FORM 10-K SUMMARY

3K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

WEST PHARMACEUTICAL SERVICES, INC.

(Registrant)

By: /s/ Bernard J. Birkett

Bernard J. Birkett

Senior Vice President, Chief Financial Officer

February 18, 2025

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of West Pharmaceutical Services, Inc. and in the capacities and on the dates indicated.


Signature	Title	Date
/s/ Eric M. Green	President, Chief Executive Officer and Chair of the Board	February 18, 2025
Eric M. Green	(Principal Executive Officer)

/s/ Bernard J. Birkett	Senior Vice President, Chief Financial Officer	February 18, 2025
Bernard J. Birkett	(Principal Financial Officer)

/s/ Chad R. Winters	Vice President, Finance & Chief Accounting Officer	February 18, 2025
Chad R. Winters	(Principal Accounting Officer)

/s/ Mark A. Buthman	Director	February 18, 2025
Mark A. Buthman

/s/ William F. Feehery, Ph.D.	Director	February 18, 2025
William F. Feehery, Ph.D.

/s/ Robert F. Friel	Director	February 18, 2025
Robert F. Friel

/s/ Janet Haugen	Director	February 18, 2025
Janet Haugen

/s/ Thomas W. Hofmann	Director	February 18, 2025
Thomas W. Hofmann

/s/ Molly E. Joseph	Director	February 18, 2025
Molly E. Joseph

/s/ Deborah L.V. Keller	Director	February 18, 2025
Deborah L.V. Keller

/s/ Myla P. Lai-Goldman, M.D.	Director	February 18, 2025
Myla P. Lai-Goldman, M.D.

/s/ Stephen Lockhart, Ph.D.	Director	February 18, 2025
Stephen Lockhart, Ph.D.

/s/ Douglas A. Michels	Director	February 18, 2025
Douglas A. Michels

/s/ Paolo Pucci	Director	February 18, 2025
Paolo Pucci

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES